BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15854668)

  • 1. Regional differences of melphalan lung levels after isolated lung perfusion in the rat.
    Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G; Van Schil PE
    J Surg Res; 2005 May; 125(2):157-60. PubMed ID: 15854668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterograde versus retrograde isolated lung perfusion with melphalan in the WAG-Rij rat.
    Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G G; De Bruijn EA; Van Schil PE
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1083-5. PubMed ID: 15896622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective pulmonary artery perfusion with melphalan is equal to isolated lung perfusion but superior to intravenous melphalan for the treatment of sarcoma lung metastases in a rodent model.
    Den Hengst WA; Hendriks JM; Van Hoof T; Heytens K; Guetens G; de Boeck G; Lardon F; Van Schil PE
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):341-7; discussion 347. PubMed ID: 22345285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of isolated lung perfusion with melphalan for resectable pulmonary metastases, a phase I and extension trial.
    Grootenboers MJ; Hendriks JM; van Boven WJ; Knibbe CA; van Putte B; Stockman B; De Bruijn E; Vermorken JB; Van Schil PE; Schramel FM
    J Surg Oncol; 2007 Dec; 96(7):583-9. PubMed ID: 17999399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated lung perfusion with melphalan: pharmacokinetics and toxicity in a pig model.
    van der Elst A; Oosterling SJ; Paul MA; Vonk AM; Sparidans RW; van der Sijp JR
    J Surg Oncol; 2006 Apr; 93(5):410-6. PubMed ID: 16550578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in flow, duration, and concentration do not change the final lung concentration of melphalan after isolated lung perfusion in rats.
    Romijn S; Hendriks JM; Van Putte BP; Guetens G; De Bruijn EA; Van Schil PE
    Eur Surg Res; 2003; 35(1):50-3. PubMed ID: 12566788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated lung perfusion for the treatment of pulmonary metastases an experimental study in the rat.
    Van Schil P; Hendriks J
    Verh K Acad Geneeskd Belg; 1999; 61(4):517-50. PubMed ID: 10500475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma.
    Nawata S; Abecasis N; Ross HM; Abolhoda A; Cheng H; Sachar KS; Burt ME
    J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1542-7; discussion 1547-8. PubMed ID: 8975846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial.
    Hendriks JM; Grootenboers MJ; Schramel FM; van Boven WJ; Stockman B; Seldenrijk CA; ten Broecke P; Knibbe CA; Slee P; De Bruijn E; Vlaeminck R; Heeren J; Vermorken JB; van Putte B; Romijn S; Van Marck E; Van Schil PE
    Ann Thorac Surg; 2004 Dec; 78(6):1919-26; discussion 1926-7. PubMed ID: 15561001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation.
    van Iersel LB; Verlaan MR; Vahrmeijer AL; van Persijn van Meerten EL; Tijl FG; Sparidans RW; Gelderblom H; Kuppen PJ; Tollenaar RA; van de Velde CJ
    Eur J Surg Oncol; 2007 Sep; 33(7):874-81. PubMed ID: 17400422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: II. High-dose cisplatin is well tolerated by the native lung tissue.
    Franke UF; Wittwer T; Kaluza M; Albert M; Becker V; Roskos M; Lessel M; Wahlers T
    Eur J Cardiothorac Surg; 2004 Oct; 26(4):800-6. PubMed ID: 15450576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary intravascular volume can be used for dose calculation in isolated lung perfusion.
    van Putte BP; Huisman A; Hendriks JM; van Schil PE; van Boven WJ; Schramel F; Nijkamp F; Folkerts G
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):594-8. PubMed ID: 16135409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model.
    Van Putte BP; Hendriks JM; Romijn S; Guetens G; De Boeck G; De Bruijn EA; Van Schil PE
    Ann Thorac Surg; 2002 Sep; 74(3):893-8; discussion 898. PubMed ID: 12238857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake.
    Rothbarth J; Sparidans RW; Beijnen JH; Schultze-Kool LJ; Putter H; van de Velde CJ; Mulder GJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):736-40. PubMed ID: 12388659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival of a phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastases.
    Den Hengst WA; Van Putte BP; Hendriks JM; Stockman B; van Boven WJ; Weyler J; Schramel FM; Van Schil PE
    Eur J Cardiothorac Surg; 2010 Nov; 38(5):621-7. PubMed ID: 20478715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melphalan antitumor efficacy and hepatotoxicity: the effect of variable infusion duration in the hepatic artery.
    Rothbarth J; Woutersen RA; Sparidans RW; van de Velde CJ; Mulder GJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1098-103. PubMed ID: 12606622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional chemotherapy via pulmonary artery with blood flow occlusion in a solitary tumor nodule model.
    Wang HY; Hochwald S; Ng B; Burt M
    Anticancer Res; 1996; 16(6B):3749-53. PubMed ID: 9042252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model.
    Glehen O; Stuart OA; Mohamed F; Sugarbaker PH
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):79-84. PubMed ID: 15048586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated lung perfusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma.
    Hendriks JM; Van Schil PE; De Boeck G; Lauwers PR; Van Oosterom AA; Van Marck EA; Eyskens EJ
    Ann Thorac Surg; 1998 Nov; 66(5):1719-25. PubMed ID: 9875778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-evaluation of toxicity and long-term follow-up of isolated lung perfusion with melphalan in patients with resectable pulmonary metastases: a phase I and extension trial.
    Grootenboers MJ; Schramel FM; van Boven WJ; van Putte BP; Hendriks JM; Van Schil PE
    Ann Thorac Surg; 2007 Mar; 83(3):1235-6. PubMed ID: 17307516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.